American health firm cancels UK IPO as valuations disappoint
American health diagnostics firm Alere called off a planned spin off of its UK business on Thursday after valuations in the country proved unsatisfactory.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: